Solventum (SOLV) Capital Expenditures (2023 - 2026)

Solventum has reported Capital Expenditures for 4 years, with the latest figure at $84.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 22.94% year-over-year to $84.0 million; the trailing twelve-month figure through Mar 2026 stood at $354.0 million (down 8.53% YoY), and the FY2025 full-year result was $379.0 million, changed 0.26% from the prior year.
• Capital Expenditures for Q1 2026 stood at $84.0 million, up from $63.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $127.0 million in Q4 2024, with the low at $58.0 million in Q2 2024.
• Historically, Capital Expenditures has averaged $87.2 million across 4 years, with a median of $88.0 million in 2023.
• The largest YoY upside for Capital Expenditures was 89.66% in 2025 against a maximum downside of 50.39% in 2025.
• Solventum's Capital Expenditures stood at $88.0 million in 2023, then soared by 44.32% to $127.0 million in 2024, then plunged by 50.39% to $63.0 million in 2025, then jumped by 33.33% to $84.0 million in 2026.
• The last three Capital Expenditures figures came in at $84.0 million (Q1 2026), $63.0 million (Q4 2025), and $97.0 million (Q3 2025), per Business Quant data.